13.12.2019 capsensixx AG  DE000A2G9M17

DGAP-News: capsensixx AG: 2020 EBITDA (after shares of third parties) of EUR 3.2 to 3.5 million anticipated


 

DGAP-News: capsensixx AG / Key word(s): Letter of Intent/Disposal
capsensixx AG: 2020 EBITDA (after shares of third parties) of EUR 3.2 to 3.5 million anticipated
13.12.2019 / 08:37
The issuer is solely responsible for the content of this announcement.



capsensixx AG signs LOI for the sale of coraixx GmbH & Co. KGaA to the management

- 2020 EBITDA (after shares of third parties) of EUR 3.2 to 3.5 million anticipated

Frankfurt am Main, 13. December 2019 - capsensixx AG (ISIN DE000A2G9M17) today signed a letter of intent (LOI) in connection with an intended management buyout concerning its equity interest in coraixx GmbH & Co. KGaA with Sven Ulbrich. Providing the transaction will be implemented, it will have a negative one-off effect of around EUR 1.7 million on earnings in capsensixx AG's single-entity financial statements pursuant to the German Commercial Code (HGB) in the fourth quarter of 2019 while there will be a positive effect of around EUR 0.2 million on capsensixx's consolidated earnings (IFRS) in the same period. Going forward, capsensixx AG's earnings will no longer be impacted by operative loss-making coraixx GmbH & Co. KGaA. Similarly, the focussing will result in significantly lower costs on a holding level already from 2020 onwards in an amount of more than EUR 0.5 million per year.

After it will have given up its equity interest in coraixx GmbH & Co. KGaA, capsensixx will concentrate on its core investments Axxion S.A. and Oaklet GmbH, which have been profitable for years. In the addressed segments Fund Management, Administration & Accounting and Capital Markets & Corporate Services, capabilities and offers can hence be strengthened and supplemented in a market environment characterised by consolidation. Against the backdrop of a streamlined group structure capsensixx anticipates for 2020 earnings before interest, taxes, depreciation and amortisation (EBITDA / after shares of third parties) of EUR 3.2 to 3.5 million.

Within the context of sharpening capsensixx AG's business focus, the current member of the Supervisory Board Gregor Langer is to be appointed to the Management Board. CEO Sven Ulbrich leaves the Management Board of capsensixx AG with immediate effect and concentrate in future fully on his activity as managing director of Oaklet GmbH.

Contact:

capsensixx AG
Bettinastraße 57-59
D-60325 Frankfurt am Main
Tel. 069 / 7680 585 0
Fax. 069 / 7680 585 20
Email: capsensixx@edicto.de

Media Relations
edicto GmbH
Axel Mühlhaus/ Dr. Sönke Knop
Tel. +49(0) 69/905505-52
Email: capsensixx@edicto.de



13.12.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: capsensixx AG
Bettinastraße 57-59
60325 Frankfurt
Germany
E-mail: capsensixx@edicto.de
Internet: www.capsensixx.de
ISIN: DE000A2G9M17
WKN: A2G9M1
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 935587

 
End of News DGAP News Service

935587  13.12.2019 

fncls.ssp?fn=show_t_gif&application_id=935587&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2013 2014 2015 2016 2017 2018 2019 2020e
Umsatzerlöse1 0,00 0,00 69,46 65,54 116,20 116,66 112,21 0,00
EBITDA1,2 0,00 0,00 7,45 6,56 8,17 7,86 10,12 0,00
EBITDA-Marge3 0,00 0,00 10,73 10,01 7,03 6,74 9,02 0,00
EBIT1,4 0,00 0,00 6,88 5,81 7,19 4,46 7,25 0,00
EBIT-Marge5 0,00 0,00 9,90 8,86 6,19 3,82 6,46 0,00
Jahresüberschuss1 0,00 0,00 4,83 4,07 4,98 2,34 5,08 0,00
Netto-Marge6 0,00 0,00 6,95 6,21 4,29 2,01 4,53 0,00
Cashflow1,7 0,00 0,00 5,23 3,14 5,95 5,81 0,74 0,00
Ergebnis je Aktie8 0,00 0,00 0,71 0,60 0,74 -0,25 0,70 0,30
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2019 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Baker Tilly

INVESTOR-INFORMATIONEN
©boersengefluester.de
Capsensixx
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A2G9M1 12,400 Halten 42,53
KGV 2021e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
27,56 19,85 1,388 26,61
KBV KCV KUV EV/EBITDA
3,65 57,32 0,38 3,430
Dividende '19 in € Dividende '20e in € Div.-Rendite '19e
in %
Hauptversammlung
0,00 0,00 0,00 13.10.2020
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
28.05.2020 28.08.2020 27.11.2020 27.04.2020
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
11,78% 46,85% 65,33% 36,26%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu capsensixx AG  ISIN: DE000A2G9M17 können Sie bei DGAP abrufen

Finanzdienstleistungen , A2G9M1 , CPX , XETR:CPX